Issuer · CIK 0001638097

ENTX — Entera Bio Ltd.

Recent filings

May 8, 2026·Form 4·Pro · in 17h 42m$•••K
ENTX/Entera Bio Ltd.
Yaacov-Garbeli Dana · Chief Financial Officer
Proonly
May 8, 2026·Form 4·Pro · in 17h 41m$•••K
ENTX/Entera Bio Ltd.
Burshtein Gregory · Chief of R&D
Proonly

← Back to all filings